Suscripción a Biblioteca: Guest
Critical Reviews™ in Oncogenesis

Publicado 4 números por año

ISSN Imprimir: 0893-9675

ISSN En Línea: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

Iron, Erythropoietic Stimulating Agents, and Anemia in Cancer

Volumen 18, Edición 5, 2013, pp. 471-483
DOI: 10.1615/CritRevOncog.2013007889
Get accessGet access

SINOPSIS

Anemia commonly accompanies malignancies in patients and may contribute to morbidity. Correction of the anemia with erythropoietic stimulating agents, while possible, may be associated with complications such as tumor progression and adverse cardiovascular events. This review examines the data behind these concerns and raises the strategy of using iron, alone, in the setting of cancer-associated anemia to reduce exposure to transfusions in these patients and to potentially improve their quality of life.

CITADO POR
  1. Beguin Yves, Aapro Matti, Ludwig Heinz, Mizzen Lee, Österborg Anders, Epidemiological and nonclinical studies investigating effects of iron in carcinogenesis—A critical review, Critical Reviews in Oncology/Hematology, 89, 1, 2014. Crossref

  2. Lang Elisabeth, Bissinger Rosi, Qadri Syed M., Lang Florian, Suicidal death of erythrocytes in cancer and its chemotherapy: A potential target in the treatment of tumor-associated anemia, International Journal of Cancer, 141, 8, 2017. Crossref

  3. Li Chengyin, Zhu Fenglin, Xu Chong, Xiao Ping, Wen Junsong, Zhang Xia, Wu Bin, Dangguibuxue decoction abolishes abnormal accumulation of erythroid progenitor cells induced by melanoma, Journal of Ethnopharmacology, 242, 2019. Crossref

  4. Gitlin-Domagalska Agata, Mangold Martin, Dębowski Dawid, Ptaszyńska Natalia, Łęgowska Anna, Gütschow Michael, Rolka Krzysztof, Matriptase-2: monitoring and inhibiting its proteolytic activity, Future Medicinal Chemistry, 10, 23, 2018. Crossref

  5. Makharadze Tamta, Boccia Ralph, Krupa Anna, Blackman Nicole, Henry David H., Gilreath Jeffrey A., Efficacy and safety of ferric carboxymaltose infusion in reducing anemia in patients receiving chemotherapy for nonmyeloid malignancies: A randomized, p lacebo‐controlled study ( IRON ‐ CLAD ) , American Journal of Hematology, 96, 12, 2021. Crossref

Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones Precios y Políticas de Suscripcione Begell House Contáctenos Language English 中文 Русский Português German French Spain